Intercept Pharmaceuticals, Inc.
ICPT · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$174,858 | -$91,426 | -$274,880 | -$344,681 |
| Dep. & Amort. | $592 | $2,978 | $3,118 | $3,663 |
| Deferred Tax | $0 | -$11,776 | $4,241 | $2,380 |
| Stock-Based Comp. | $21,889 | $33,888 | $60,850 | $55,982 |
| Change in WC | $21,917 | -$14,417 | $1,999 | $19,331 |
| Other Non-Cash | $103,680 | $39,114 | $34,646 | $26,712 |
| Operating Cash Flow | -$26,780 | -$41,639 | -$170,026 | -$236,613 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$568 | -$397 | -$3,891 | -$1,136 |
| Net Acquisitions | $0 | -$71,123 | -$166,708 | $187,852 |
| Inv. Purchases | -$552,737 | -$349,457 | -$330,713 | -$603,014 |
| Inv. Sales/Matur. | $451,921 | $420,580 | $497,421 | $415,162 |
| Other Inv. Act. | $363,233 | $71,123 | $166,708 | -$187,852 |
| Investing Cash Flow | $261,849 | $70,726 | $162,817 | -$188,988 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $227,260 |
| Stock Repurch. | -$557 | -$75,825 | -$1,994 | -$2,158 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$267,316 | $1,118 | -$693 | $457,519 |
| Financing Cash Flow | -$267,316 | $1,118 | -$693 | $457,519 |
| Forex Effect | -$6,302 | -$1,450 | -$1,224 | -$386 |
| Net Chg. in Cash | -$38,549 | $28,755 | -$9,126 | $31,532 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $94,409 | $65,654 | $74,780 | $43,248 |
| End Cash | $55,860 | $94,409 | $65,654 | $74,780 |
| Free Cash Flow | -$27,348 | -$42,036 | -$173,917 | -$237,749 |